Anika Therapeutics (ANIK) Inventory (2010 - 2026)
Anika Therapeutics (ANIK) posted quarterly Inventory of $28.6 million for Q2 2026, up 68.8% year-over-year from $16.9 million in Q2 2025, and up 25.08% quarter-over-quarter from $22.8 million in Q1 2026.
Anika Therapeutics (ANIK) Inventory (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Inventory for 17 consecutive years, with $28.6 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Inventory rose 68.8% year-over-year to $28.6 million; the TTM figure through Jun 2026 stood at $28.6 million (up 68.8% YoY), while the FY2025 annual figure was $18.8 million, down 21.09% from the prior year.
- Inventory rose to $28.6 million in Q2 2026 per ANIK's latest filing, from $22.8 million in the prior quarter.
- Across five years, Inventory topped out at $51.5 million in Q2 2024 and bottomed at $16.3 million in Q3 2025.
- Historically, Inventory has averaged $32.7 million across 5 years, with a median of $35.3 million in 2022.
- Annual changes were most pronounced in 2025 — Inventory plunged 67.12% — and 2026, when it jumped 68.8%.
- Anika Therapeutics' Inventory stood at $39.8 million in 2022, then slumped by 38.57% to $24.4 million in 2023, then decreased by 2.53% to $23.8 million in 2024, then declined by 21.09% to $18.8 million in 2025, then surged by 52.05% to $28.6 million in 2026.
- Business Quant data shows ANIK's Inventory at $28.6 million in Q2 2026, $22.8 million in Q1 2026, and $18.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 1.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 3.22 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 2.57 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 9.08 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 193.80 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.77 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 816.00 Mn |
| 10 | Anika Therapeutics | 283.53 Mn | 245.12 Mn | 21.24 Mn | 28.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 28.57 Mn |
| Mar 31, 2026 | 22.84 Mn |
| Dec 31, 2025 | 18.79 Mn |
| Sep 30, 2025 | 16.28 Mn |
| Jun 30, 2025 | 16.92 Mn |
| Mar 31, 2025 | 21.34 Mn |
| Dec 31, 2024 | 23.81 Mn |
| Sep 30, 2024 | 39.63 Mn |
| Jun 30, 2024 | 51.46 Mn |
| Mar 31, 2024 | 49.41 Mn |
| Dec 31, 2023 | 24.43 Mn |
| Sep 30, 2023 | 43.72 Mn |
| Jun 30, 2023 | 42.60 Mn |
| Mar 31, 2023 | 41.32 Mn |
| Dec 31, 2022 | 39.77 Mn |
| Sep 30, 2022 | 37.24 Mn |
| Jun 30, 2022 | 35.34 Mn |
| Mar 31, 2022 | 35.23 Mn |
| Dec 31, 2021 | 36.01 Mn |
| Sep 30, 2021 | 35.02 Mn |